Survey taken by pharma and CRO executives evaluates how effectively various programs convert RWD into usable data.
Michael Howley PA-C, MBA, PhD
Advertisement
Articles by Michael Howley PA-C, MBA, PhD
Survey taken by pharma and CRO executives evaluates attributes of large datasets.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research
3
Bristol Myers Squibb Expands its Strategic Collaboration with Sarah Cannon Research Institute
4
AstraZeneca Stock Becomes UK’s Biggest Stock
5
